Related Experiment Video
Updated: May 30, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Protein C anticoagulant system--anti-inflammatory effects
1Laboratory of Coagulation Biology, Oklahoma Medical Research Foundation, Oklahoma, OK 73104, USA. esmonc@omrf.org
Activated protein C (APC) prevents disease by reducing blood clots and protecting cells. This protein signaling pathway offers potential for new therapeutic strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Activated protein C (APC) exhibits protective functions in various disease processes.
- APC's anticoagulant and cytoprotective activities limit procoagulant surface exposure on cells.
- APC signaling pathways modulate apoptosis, inflammation, endothelial barrier function, and gene expression.
Purpose of the Study:
- To elucidate the multifaceted roles of Activated Protein C (APC) in disease prevention.
- To understand the molecular mechanisms underlying APC's cytoprotective and anti-inflammatory effects.
- To explore the therapeutic potential of targeting APC-mediated signaling pathways.
Main Methods:
- Investigated APC's anticoagulant and cytoprotective activities.
- Examined APC's effects on cellular apoptosis and inflammation.
- Analyzed APC's role in regulating endothelial barrier function and gene expression.
- Studied the involvement of endothelial protein C receptor (EPCR) and PAR1/PARs in APC signaling.
- Assessed the contribution of CD11b to APC-mediated cellular responses.
Main Results:
- APC demonstrates direct anticoagulant activity, augmented by cytoprotective effects.
- APC signaling prevents apoptosis, reduces inflammation, and enhances endothelial barrier function.
- APC binding to EPCR, with PAR1 activation, mediates many of these functions.
- Other PARs and CD11b also play roles in supporting APC signaling.
- Selective modulation of these pathways is feasible.
Conclusions:
- Activated protein C (APC) possesses significant disease-preventing capabilities through diverse mechanisms.
- APC's interactions with EPCR and other receptors mediate crucial cytoprotective and anti-inflammatory effects.
- Targeting APC signaling pathways presents a promising avenue for novel therapeutic interventions in various diseases.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Inflammation III: Local and Systemic Effects
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
